Baidu
map

Transfusion:红细胞表面糖蛋白 A 的自身抗体影响循环白细胞的激活状态

2021-11-25 MedSci原创 MedSci原创

外周血中的中性粒细胞和单核细胞暴露于针对 RBC 表面 GPA 的抗体,例如 M 或 N 抗原,可能会引发活化表型。

M 和 N 等位基因都编码糖蛋白 A (GPA) 上的抗原,GPA 是一种红细胞 (RBC) 表面唾液酸糖蛋白。RBC GPA 和白细胞表面凝集素之间的相互作用可能会下调它们的激活。目前的研究调查了 RBC 针对 GPA 的自身抗体,例如自身抗 M/N,是否会引发外周血白细胞中的活化表型。



在来自自身抗 GPA(抗 M/N)患者的全血中评估白细胞活化,并与具有异体抗 M/N 的患者和健康受试者进行比较。对来自没有与抗 GPA 或抗 Rh 体外孵育的抗体的健康受试者的对照样品进行分析,以确定中性粒细胞和单核细胞表面活化标记的表达、活性氧 (ROS) 含量以及与 RBC 的聚集体的形成。用 IgG1 同种型抗体孵育的样品作为对照。

表1:自体抗M或同种异体抗M/N抗体患者的特征

表2:全血细胞计数(平均±标准差)

图1:白细胞表面活化标记物的体内和外表达

图2:体外检测白细胞和细胞内ROS的含量

 

图3:中性粒细胞-红细胞在体外聚集

与异体抗 M/N 患者(p = .1757;p = .0698)和健康受试者(p = .0186;p = .013)。在体外,与抗-Rh(p = .0003;p = .0328)和同种型对照(p = .000;p = .0062)相比,与抗 GPA 孵育后中性粒细胞 CD66b 和单核细胞 CD63 表面表达增加。与抗-Rh(p = .0012;p = .0693)和同种型对照(p = .001;p = .0021)相比,用抗 GPA 孵育的嗜中性粒细胞和单核细胞的细胞内 ROS 含量均增加。与同种型对照相比,用抗 GPA 孵育时中性粒细胞-RBC 聚集体的百分比降低(p < .01)。

 

综上所述,外周血中的中性粒细胞和单核细胞暴露于针对 RBC 表面 GPA 的抗体,例如 M 或 N 抗原,可能会引发活化表型。

 

原始出处:

Klein, MNLarkin, EJMarshall, JNFan, XParry, PTirouvanziam, R, et al. Autoantibodies to red blood cell surface Glycophorin A impact the activation poise of circulating leukocytesTransfusion20211– 10https://doi.org/10.1111/trf.16746

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1720720, encodeId=6cf41e20720fb, content=<a href='/topic/show?id=8163e726a0' target=_blank style='color:#2F92EE;'>#Fusion#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7726, encryptionId=8163e726a0, topicName=Fusion)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f10932951504, createdName=tcm110hq, createdTime=Tue May 24 04:37:06 CST 2022, time=2022-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1795831, encodeId=9a581e9583182, content=<a href='/topic/show?id=b3f81e747da' target=_blank style='color:#2F92EE;'>#Transfusion#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17747, encryptionId=b3f81e747da, topicName=Transfusion)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/WQ1WyMBGic8d2fKdCe6Cm3vaRh4X8YnlumYndC46iagNCBl9Df8RtoCaQchnFtZldHUctGJjsgsyutUlu8vPq6yQ/132, createdBy=97862500016, createdName=ms3117646317107274, createdTime=Mon Jul 25 07:37:06 CST 2022, time=2022-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1657581, encodeId=04a5165e581ae, content=<a href='/topic/show?id=3ca31e71903' target=_blank style='color:#2F92EE;'>#TRA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17719, encryptionId=3ca31e71903, topicName=TRA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=757b24868428, createdName=bsmagic9140, createdTime=Tue Sep 06 23:37:06 CST 2022, time=2022-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073825, encodeId=286d10e3825d3, content=好文共享之。, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, createdBy=88b489038, createdName=yangchou, createdTime=Thu Nov 25 12:56:16 CST 2021, time=2021-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1282095, encodeId=19741282095a1, content=<a href='/topic/show?id=3dece71531e' target=_blank style='color:#2F92EE;'>#红细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77153, encryptionId=3dece71531e, topicName=红细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c22f171, createdName=kord1982, createdTime=Thu Nov 25 07:37:06 CST 2021, time=2021-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1627263, encodeId=3188162e263ef, content=<a href='/topic/show?id=8ea0e6863a2' target=_blank style='color:#2F92EE;'>#糖蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76863, encryptionId=8ea0e6863a2, topicName=糖蛋白)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d6621112920, createdName=chentianping, createdTime=Thu Nov 25 07:37:06 CST 2021, time=2021-11-25, status=1, ipAttribution=)]
    2022-05-24 tcm110hq
  2. [GetPortalCommentsPageByObjectIdResponse(id=1720720, encodeId=6cf41e20720fb, content=<a href='/topic/show?id=8163e726a0' target=_blank style='color:#2F92EE;'>#Fusion#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7726, encryptionId=8163e726a0, topicName=Fusion)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f10932951504, createdName=tcm110hq, createdTime=Tue May 24 04:37:06 CST 2022, time=2022-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1795831, encodeId=9a581e9583182, content=<a href='/topic/show?id=b3f81e747da' target=_blank style='color:#2F92EE;'>#Transfusion#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17747, encryptionId=b3f81e747da, topicName=Transfusion)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/WQ1WyMBGic8d2fKdCe6Cm3vaRh4X8YnlumYndC46iagNCBl9Df8RtoCaQchnFtZldHUctGJjsgsyutUlu8vPq6yQ/132, createdBy=97862500016, createdName=ms3117646317107274, createdTime=Mon Jul 25 07:37:06 CST 2022, time=2022-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1657581, encodeId=04a5165e581ae, content=<a href='/topic/show?id=3ca31e71903' target=_blank style='color:#2F92EE;'>#TRA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17719, encryptionId=3ca31e71903, topicName=TRA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=757b24868428, createdName=bsmagic9140, createdTime=Tue Sep 06 23:37:06 CST 2022, time=2022-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073825, encodeId=286d10e3825d3, content=好文共享之。, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, createdBy=88b489038, createdName=yangchou, createdTime=Thu Nov 25 12:56:16 CST 2021, time=2021-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1282095, encodeId=19741282095a1, content=<a href='/topic/show?id=3dece71531e' target=_blank style='color:#2F92EE;'>#红细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77153, encryptionId=3dece71531e, topicName=红细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c22f171, createdName=kord1982, createdTime=Thu Nov 25 07:37:06 CST 2021, time=2021-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1627263, encodeId=3188162e263ef, content=<a href='/topic/show?id=8ea0e6863a2' target=_blank style='color:#2F92EE;'>#糖蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76863, encryptionId=8ea0e6863a2, topicName=糖蛋白)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d6621112920, createdName=chentianping, createdTime=Thu Nov 25 07:37:06 CST 2021, time=2021-11-25, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1720720, encodeId=6cf41e20720fb, content=<a href='/topic/show?id=8163e726a0' target=_blank style='color:#2F92EE;'>#Fusion#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7726, encryptionId=8163e726a0, topicName=Fusion)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f10932951504, createdName=tcm110hq, createdTime=Tue May 24 04:37:06 CST 2022, time=2022-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1795831, encodeId=9a581e9583182, content=<a href='/topic/show?id=b3f81e747da' target=_blank style='color:#2F92EE;'>#Transfusion#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17747, encryptionId=b3f81e747da, topicName=Transfusion)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/WQ1WyMBGic8d2fKdCe6Cm3vaRh4X8YnlumYndC46iagNCBl9Df8RtoCaQchnFtZldHUctGJjsgsyutUlu8vPq6yQ/132, createdBy=97862500016, createdName=ms3117646317107274, createdTime=Mon Jul 25 07:37:06 CST 2022, time=2022-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1657581, encodeId=04a5165e581ae, content=<a href='/topic/show?id=3ca31e71903' target=_blank style='color:#2F92EE;'>#TRA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17719, encryptionId=3ca31e71903, topicName=TRA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=757b24868428, createdName=bsmagic9140, createdTime=Tue Sep 06 23:37:06 CST 2022, time=2022-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073825, encodeId=286d10e3825d3, content=好文共享之。, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, createdBy=88b489038, createdName=yangchou, createdTime=Thu Nov 25 12:56:16 CST 2021, time=2021-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1282095, encodeId=19741282095a1, content=<a href='/topic/show?id=3dece71531e' target=_blank style='color:#2F92EE;'>#红细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77153, encryptionId=3dece71531e, topicName=红细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c22f171, createdName=kord1982, createdTime=Thu Nov 25 07:37:06 CST 2021, time=2021-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1627263, encodeId=3188162e263ef, content=<a href='/topic/show?id=8ea0e6863a2' target=_blank style='color:#2F92EE;'>#糖蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76863, encryptionId=8ea0e6863a2, topicName=糖蛋白)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d6621112920, createdName=chentianping, createdTime=Thu Nov 25 07:37:06 CST 2021, time=2021-11-25, status=1, ipAttribution=)]
    2022-09-06 bsmagic9140
  4. [GetPortalCommentsPageByObjectIdResponse(id=1720720, encodeId=6cf41e20720fb, content=<a href='/topic/show?id=8163e726a0' target=_blank style='color:#2F92EE;'>#Fusion#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7726, encryptionId=8163e726a0, topicName=Fusion)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f10932951504, createdName=tcm110hq, createdTime=Tue May 24 04:37:06 CST 2022, time=2022-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1795831, encodeId=9a581e9583182, content=<a href='/topic/show?id=b3f81e747da' target=_blank style='color:#2F92EE;'>#Transfusion#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17747, encryptionId=b3f81e747da, topicName=Transfusion)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/WQ1WyMBGic8d2fKdCe6Cm3vaRh4X8YnlumYndC46iagNCBl9Df8RtoCaQchnFtZldHUctGJjsgsyutUlu8vPq6yQ/132, createdBy=97862500016, createdName=ms3117646317107274, createdTime=Mon Jul 25 07:37:06 CST 2022, time=2022-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1657581, encodeId=04a5165e581ae, content=<a href='/topic/show?id=3ca31e71903' target=_blank style='color:#2F92EE;'>#TRA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17719, encryptionId=3ca31e71903, topicName=TRA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=757b24868428, createdName=bsmagic9140, createdTime=Tue Sep 06 23:37:06 CST 2022, time=2022-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073825, encodeId=286d10e3825d3, content=好文共享之。, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, createdBy=88b489038, createdName=yangchou, createdTime=Thu Nov 25 12:56:16 CST 2021, time=2021-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1282095, encodeId=19741282095a1, content=<a href='/topic/show?id=3dece71531e' target=_blank style='color:#2F92EE;'>#红细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77153, encryptionId=3dece71531e, topicName=红细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c22f171, createdName=kord1982, createdTime=Thu Nov 25 07:37:06 CST 2021, time=2021-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1627263, encodeId=3188162e263ef, content=<a href='/topic/show?id=8ea0e6863a2' target=_blank style='color:#2F92EE;'>#糖蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76863, encryptionId=8ea0e6863a2, topicName=糖蛋白)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d6621112920, createdName=chentianping, createdTime=Thu Nov 25 07:37:06 CST 2021, time=2021-11-25, status=1, ipAttribution=)]
    2021-11-25 yangchou

    好文共享之。

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1720720, encodeId=6cf41e20720fb, content=<a href='/topic/show?id=8163e726a0' target=_blank style='color:#2F92EE;'>#Fusion#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7726, encryptionId=8163e726a0, topicName=Fusion)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f10932951504, createdName=tcm110hq, createdTime=Tue May 24 04:37:06 CST 2022, time=2022-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1795831, encodeId=9a581e9583182, content=<a href='/topic/show?id=b3f81e747da' target=_blank style='color:#2F92EE;'>#Transfusion#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17747, encryptionId=b3f81e747da, topicName=Transfusion)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/WQ1WyMBGic8d2fKdCe6Cm3vaRh4X8YnlumYndC46iagNCBl9Df8RtoCaQchnFtZldHUctGJjsgsyutUlu8vPq6yQ/132, createdBy=97862500016, createdName=ms3117646317107274, createdTime=Mon Jul 25 07:37:06 CST 2022, time=2022-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1657581, encodeId=04a5165e581ae, content=<a href='/topic/show?id=3ca31e71903' target=_blank style='color:#2F92EE;'>#TRA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17719, encryptionId=3ca31e71903, topicName=TRA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=757b24868428, createdName=bsmagic9140, createdTime=Tue Sep 06 23:37:06 CST 2022, time=2022-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073825, encodeId=286d10e3825d3, content=好文共享之。, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, createdBy=88b489038, createdName=yangchou, createdTime=Thu Nov 25 12:56:16 CST 2021, time=2021-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1282095, encodeId=19741282095a1, content=<a href='/topic/show?id=3dece71531e' target=_blank style='color:#2F92EE;'>#红细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77153, encryptionId=3dece71531e, topicName=红细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c22f171, createdName=kord1982, createdTime=Thu Nov 25 07:37:06 CST 2021, time=2021-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1627263, encodeId=3188162e263ef, content=<a href='/topic/show?id=8ea0e6863a2' target=_blank style='color:#2F92EE;'>#糖蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76863, encryptionId=8ea0e6863a2, topicName=糖蛋白)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d6621112920, createdName=chentianping, createdTime=Thu Nov 25 07:37:06 CST 2021, time=2021-11-25, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1720720, encodeId=6cf41e20720fb, content=<a href='/topic/show?id=8163e726a0' target=_blank style='color:#2F92EE;'>#Fusion#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7726, encryptionId=8163e726a0, topicName=Fusion)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f10932951504, createdName=tcm110hq, createdTime=Tue May 24 04:37:06 CST 2022, time=2022-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1795831, encodeId=9a581e9583182, content=<a href='/topic/show?id=b3f81e747da' target=_blank style='color:#2F92EE;'>#Transfusion#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17747, encryptionId=b3f81e747da, topicName=Transfusion)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/WQ1WyMBGic8d2fKdCe6Cm3vaRh4X8YnlumYndC46iagNCBl9Df8RtoCaQchnFtZldHUctGJjsgsyutUlu8vPq6yQ/132, createdBy=97862500016, createdName=ms3117646317107274, createdTime=Mon Jul 25 07:37:06 CST 2022, time=2022-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1657581, encodeId=04a5165e581ae, content=<a href='/topic/show?id=3ca31e71903' target=_blank style='color:#2F92EE;'>#TRA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17719, encryptionId=3ca31e71903, topicName=TRA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=757b24868428, createdName=bsmagic9140, createdTime=Tue Sep 06 23:37:06 CST 2022, time=2022-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073825, encodeId=286d10e3825d3, content=好文共享之。, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, createdBy=88b489038, createdName=yangchou, createdTime=Thu Nov 25 12:56:16 CST 2021, time=2021-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1282095, encodeId=19741282095a1, content=<a href='/topic/show?id=3dece71531e' target=_blank style='color:#2F92EE;'>#红细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77153, encryptionId=3dece71531e, topicName=红细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c22f171, createdName=kord1982, createdTime=Thu Nov 25 07:37:06 CST 2021, time=2021-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1627263, encodeId=3188162e263ef, content=<a href='/topic/show?id=8ea0e6863a2' target=_blank style='color:#2F92EE;'>#糖蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76863, encryptionId=8ea0e6863a2, topicName=糖蛋白)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d6621112920, createdName=chentianping, createdTime=Thu Nov 25 07:37:06 CST 2021, time=2021-11-25, status=1, ipAttribution=)]

相关资讯

AP&T: 基于较低的6-TGN目标水平调整硫唑嘌呤剂量白细胞减少并发症的发生

NUDT15基因多态性与硫嘌呤诱导的白细胞减少症之间的关联是确定的,本项研究旨在探讨接受硫唑嘌呤的炎性肠病(IBD)患儿的NUDT15基因多态性与白细胞减少时间的关系.

突然降低的白细胞

5月1日,由120急救接回来的84岁陈奶奶,因持续性低烧两天并未进食,被收治住院。查体:体温37.8°经管医师立即要求查血常规+CRP,结果显示为WBC:11.87*10^9/L Neu%:92.9

尿中白细胞增多的元凶竟然是“它们”!

随着人们生活水平的不断提升,人们对自身的健康越来越重视,为了防患于未然,不论是单位组织还是个人每年都会到医院进行查体,这其中尿常规检查是健康查体的重要项目,可以发现肾脏、输尿管、膀胱等器官的一些病变。

临床上用到的升白细胞药物整理

粒细胞缺乏的典型表现为感染引起的发热,是临床上需要立即处理的急症。

令人匪夷所思的白细胞,是何原因?

5月1日,由120急救接回来的84岁陈奶奶,因持续性低烧两天并未进食,被收治住院。

AP&T:白细胞比例是急性肝硬化失代偿和慢性肝功能衰竭患者死亡的预测生物标志

肝硬化在全球范围内都是很严重的公共卫生问题,肝硬化导致的急性代偿失调(AD)和随后的慢性慢性肝功能衰竭(ACLF)都会导致其发病率上升。

拓展阅读

红细胞明显升高就是“真红”吗?不一定,也许是罕见病

TEMPI综合征是一种与浆细胞肿瘤相关的副肿瘤综合征。

总胆红素、直接胆红素、间接胆红素升高的临床意义

胆红素升高的具体原因是什么呢?本文从红细胞破坏过多、肝细胞病变、胆汁排泄受阻等 7 个方面进行了分析。

Blood:施均/初雅婧/袁卫平发现线粒体tRNA假尿嘧啶化控制红细胞生成

该研究揭示了tRNA假尿嘧啶化在红细胞生成中的作用及其与线粒体肌病、乳酸性酸中毒和铁粒幼细胞性贫血(MLASA)发病机制的关系。

BJH:输注遗传性血色素沉着症捐献者的红细胞可改善患者的血红蛋白增量

这项研究的发现补充了现有的文献来鼓励实践的改变:接受HH患者的献血可以改善患者的输血结果,同时提高血液的可用性。

糖化血红蛋白未出数值,为何?

是何原因引起的不出数值?本实验室采用的糖化血红蛋白分析仪的型号是TOSOH HLC-723G8,试剂、校准品均为配套试剂,方法为离子交换高效液相色谱法(HPLC)。

阿司匹林、氯吡格雷……一文了解6种常用抗血小板药物

阿司匹林、氯吡格雷……一文了解6种常用抗血小板药物

Baidu
map
Baidu
map
Baidu
map